Biblio Discovery — Demo Discovery Service

456 hasil

Menampilkan 1–20 · 0,23 detik · RSS

Jurnal

Onkologija

Scopus

ISSN 1408-1741 · Institute of Oncology Ljubljana · 456 artikel di indeks

  1. Artikel Jurnal

    Uspešno genetsko testiranje 59 let starega vzorca tkiva

    Vita Šetrajčič Dragoš; Vida Stegel; Olga Blatnik dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Predstavljamo uspešno genetsko analizo 59 let starega, arhivskega, v formalinu fiksiranega in v parafin vklopljenega (FFPE) vzorca tkiva z namenom opredelitve dedne predispozicije za razvoj raka. V družinah z obremenilno družinsko anamnezo raka, kjer ključni oboleli sorodniki niso več živi, je…

  2. Artikel Jurnal

    Akupunktura v onkologiji

    Iztok Potočnik; Vlasta Orlić Karbić

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Preživetje slovenskih bolnikov z rakom se v zadnjih desetletjih vztrajno izboljšuje, kar odraža napredek slovenske onkologije in nacionalnega zdravstvenega sistema. Državni program obvladovanja raka zagotavlja integriran okvir dejavnosti na področju preventive, diagnostike, zdravljenja…

  3. Artikel Jurnal

    Radiotherapy intensity in patients with advanced solid cancer at the end-of-life

    Nena Golob

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Introduction: Advances in oncology have raised questions about the appropriateness of treatment at the end of life. Palliative radiotherapy is not currently considered an indicator of aggressive end-of-life care. This study aimed to evaluate the use of specific oncological treatments in patients…

  4. Artikel Jurnal

    Transcriptomic stratification of advanced primary endometrial tumors by mismatch repair status

    Marija Gjorgoska; Tea Lanišnik Rižner

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Background: Endometrial cancer (EC) is one of the most common gynaecological malignancies in developed countries and has a poor prognosis in advanced disease. The introduction of adjuvant treatment with immunotherapy has significantly improved survival in patients with advanced EC with deficient…

  5. Artikel Jurnal

    Soft tissue sarcomas

    Marko Novak; Nina Turnšek; Mojca Unk dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Recommendations for the management and treatment of patients with soft tissue sarcoma emphasize the importance of individualized treatment in a referral center with a multidisciplinary sarcoma team. The only referral sarcoma center in Slovenia is the Institute of Oncology Ljubljana. Key components…

  6. Artikel Jurnal

    Clinical recommendations for the management of radiodermatitis and radiomucositis

    Sandra Gole; Martina Goličnik; Vesna Jašič dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Radiotherapy is an important part of modern cancer treatment, but it often causes side effects on the skin and mucous membranes, the most common of which are radiodermatitis and radiomucositis. The purpose of these professional recommendations is to standardize patient care, improve the recognition…

  7. Artikel Jurnal

    Impact of mean heart dose on mortality after high-dose radiotherapy for lung cancer

    Katja Šketa; Anja Tomazin; Ivica Ratoša dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Background: Cardiovascular complications represent an important late adverse effect of thoracic radiotherapy in patients with lung cancer. Mean heart dose (MHD) is a commonly used dosimetric parameter in radiotherapy planning; however, the optimal threshold associated with patient survival has not…

  8. Artikel Jurnal

    Comparative analysis of two radiotherapy approaches within total neoadjuvant therapy for high-risk locally advanced rectal cancer

    Manuel Ramanović; Erik Brecelj; Franc Anderluh dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Background: Total neoadjuvant therapy (TNT) has become a standard of care for patients with locally advanced rectal cancer (LARC) who present with high risk features on magnetic resonance imaging (MRI). Despite its increasing adoption, the optimal sequencing of individual treatment components and…

  9. Artikel Jurnal

    Implantable intrathecal pumps for refractory cancer pain

    Teodora Zupanc; Branka Stražišar; Aljoša Škorjanc dkk.

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Cancer pain is often inadequately managed with standard systemic therapies. Targeted intrathecal administration of analgesics via implantable (internal) intrathecal pumps may improve analgesia and reduce systemic adverse effects. However, treatment with external pumps may place a substantial burden…

  10. Artikel Jurnal

    An overview of recommendations for genetic and preventive management of patients with Li-Fraumeni syndrome

    Maša Smrdel; Mateja Krajc; Ana Blatnik

    Onkologija, Vol. 30 No. 1 · 2026 · Slovenia · DOAJ Scopus

    Germline pathogenic variants in the TP53 gene are associated with an increased risk of developing cancer. The most penetrant of these variants are associated with Li-Fraumeni syndrome (LFS), a rare hereditary cancer predisposition syndrome. In this overview, we aim to present the genetic causes and…

  11. Artikel Jurnal

    Cancer burden in Kanal ob Soči Municipality and Goriška Statistical Region (Slovenia) and potential association with environmental pollutants due to waste co-incineration

    Vesna Zadnik; Teja Oblak; Amela Duratović Konjević dkk.

    Onkologija (2025) · 2025 · Slovenia · DOAJ Scopus

    Background: In the municipality of Kanal ob Soči, residents are exposed to historical asbestos pollution and current emissions from waste co-incineration in a cement plant. This paper discusses the trends over time in the cancer burden with a focus on mesothelioma and assesses the association…

  12. Artikel Jurnal

    Nevrološki zapleti zdravljenja z zaviralci imunskih nadzornih točk

    Nadja Novak Bošnjak; Aljoša Andlovic

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Pomembnemu ugodnemu učinku zdravljenja z zaviralci imunskih nadzornih točk so relativno pogosto pridruženi neželeni zapleti, med katerimi so nevrološki redki, a lahko življenje ogrožujoči. V prispevku so predstavljeni nevrološki zapleti zdravljenja z zaviralci imunskih nadzornih točk. Podana…

  13. Artikel Jurnal

    Modern radiotherapy

    Angel Montero-Luis; Ivica Ratoša; Helena Barbara Zobec Logar

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    The evolution of modern radiotherapy aligns seamlessly with the principles of Citius, Altius, Fortius—faster, higher, stronger— while embracing the Less is More philosophy. In recent years, the 5-fraction radiotherapy regimen has emerged as a transformative approach, offering shorter treatment…

  14. Artikel Jurnal

    S kemoterapijo povzročena periferna polinevropatija (CIPN)

    Katja Dejanović; Aljoša Andlovic; Breda Škrbinc

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    S kemoterapijo povzročena periferna polinevropatija (CIPN) je disfunkcija perifernega živčevja kot posledica zdravljenja z enim ali s kombinacijo več citostatikov. Najpogostejši povzročitelji CIPN so taksani, derivati platine in vinka alkaloidi, njihovi vzročni mehanizmi CIPN se razlikujejo in so…

  15. Artikel Jurnal

    Pleural, abdominal, and pericardial lymphocytic effusion

    Veronika Kloboves Prevodnik; Živa Ledinek; Aleš Rode dkk.

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Lymphocytic effusion is a complication of several diseases. The main causes of most lymphocytic effusions are malignomas and tuberculosis. Lymphocytes in effusion can be reactive or neoplastic. Reactive lymphocytic effusion develops due to inflammation, systemic and autoimmune diseases, carcinosis…

  16. Artikel Jurnal

    Priporočila za sistemsko onkološko in radioterapevtsko zdravljenje rakov biliarnega trakta

    Erik Brecelj; Martina Reberšek; Ajra Šečerov Ermenc dkk.

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Raki biliarnega trakta so redka in heterogena skupina z naraščajočo incidenco in visoko umrljivostjo. Imajo slabo prognozo s celokupnim preživetjem manj od 1 leta. Nova dognanja o molekularno genetski heterogenosti rakov biliarnega trakta in novi terapevtskih pristopi omogočajo tem bolnikom daljša…

  17. Artikel Jurnal

    Četrt stoletja specializacije iz internistične onkologije v Sloveniji

    Erika Matos; Simona Borštnar; Cvetka Kuhar Grašič

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Sistemsko zdravljenje dokazano izboljša preživetje številnih bolnikov z rakom. Nabor protirakavih zdravil se je v zadnjih desetletjih močno povečal, z njimi zdravimo več kot polovico obolelih. Specifičnost bolezni, specifičnost zdravljenja in zdravil, ki imajo pogosto zelo ozko terapevtsko okno, so…

  18. Artikel Jurnal

    Celostna obravnava bolnikov z rakom

    Irena Oblak; Majda Čaušević; Barbara Perić dkk.

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Napredki na področju diagnostike in zdravljenja raka pomembno prispevajo k boljšemu preživetju bolnikov z rakom, kljub temu pa se številni bolniki zaradi bolezni in zdravljenja soočajo z različnimi težavami in potrebami, ki jih onkološka obravnava ne zajema vedno. Ustrezno obvladovanje teh težav z…

  19. Artikel Jurnal

    Uvealni melanom

    Barbara Perić; Gregor Hawlina; Vladimir Debelič dkk.

    Onkologija, Vol. 29 No. 1 · 2025 · Slovenia · DOAJ Scopus

    Uvealni melanom je najpogostejši primarni maligni znotrajočesni tumor pri odraslih. Med uvealne melanome uvrščamo melanom žilnice (90 %), ciliarnika (6 %) in šarenice (4 %). Med leti 2017 in 2021 je za uvealnim melanomom v Sloveniji letno zbolelo povprečno 23 oseb, kar predstavlja 3,7 % vseh…

  20. Artikel Jurnal

    Two Decades of the Department of Molecular Diagnostics at the Institute of Oncology Ljubljana

    Petra Škerl; Srdjan Novaković; Vida Stegel

    Onkologija, Vol. 29 No. 2 · 2025 · Slovenia · DOAJ Scopus

    The Department of Molecular Diagnostics at the Institute of Oncology Ljubljana was established in 2005 at the initiative of Prof. Dr. Srdjan Novaković. Over the past 20 years, it has evolved into the central national laboratory for genetic testing of individuals with a higher risk of hereditary…